Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.
Amino acid substitutions were placed at residues 74, 243, and 246 in capsid protein VP2 of poliovirus serotype 1, using site-specific mutagenesis methods. The proximity of these residues to those previously identified in neutralization site 3B suggests that these residues may also contribute to neutralization site 3B and potentially be under antibody selective pressure to mutate. However, sequence analyses of independent serotype 1 isolates indicate high sequence conservation at these residues, suggesting selective pressures are present within the virus to maintain sequences within these loop regions. All viable mutants display partial or complete resistance to neutralization by the site 3B neutralizing monoclonal antibodies. Cross-neutralization data with the site-specifically generated viral mutants confirm that these residues do indeed contribute to forming neutralization site 3B and also identify the participation of a new loop region within site 3B. However, many amino acid substitutions generate nonviable virus mutants and even conservative amino acid substitutions produce growth-compromised virus mutants. These data suggest that previous definition of neutralization antigenic sites by isolation of neutralization resistant mutants favors detection of viable mutant viruses with more normal growth characteristics and is inherently biased against detection of neutralization antigenic sites formed by residues critical for other stages of virus replication.
Reynolds
C
C
Department of Biology, Massachusetts Institute of Technology, Cambridge 02139.
Page
G
G
Zhou
H
H
Chow
M
M
D000595:Amino Acid Sequence; D001483:Base Sequence; D002213:Capsid / Q000235:genetics / Q000276:immunology*; D036022:Capsid Proteins; D000939:Epitopes / Q000032:analysis* / Q000235:genetics; D005814:Genes, Viral; D006367:HeLa Cells / Q000502:physiology; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D010641:Phenotype; D017955:Poliovirus / Q000235:genetics / Q000276:immunology*; D011487:Protein Conformation; D014771:Virion / Q000235:genetics / Q000276:immunology*
D036022:Capsid Proteins; D000939:Epitopes; C442541:VP2 protein, Poliovirus